These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25335093)

  • 1. Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
    Xiao F; Chen J; Lian C; Han P; Zhang C
    Mol Med Rep; 2015 Jan; 11(1):739-45. PubMed ID: 25335093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective TRAIL-induced cytotoxicity to lung cancer cells mediated by miRNA response elements.
    Wu G; Ji Z; Li H; Lei Y; Jin X; Yu Y; Sun M
    Cell Biochem Funct; 2014 Oct; 32(7):547-56. PubMed ID: 25132116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.
    Yan Y; Zhang F; Fan Q; Li X; Zhou K
    Neoplasma; 2014; 61(6):672-9. PubMed ID: 25150312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA response elements-regulated TRAIL expression shows specific survival-suppressing activity on bladder cancer.
    Zhao Y; Li Y; Wang L; Yang H; Wang Q; Qi H; Li S; Zhou P; Liang P; Wang Q; Li X
    J Exp Clin Cancer Res; 2013 Feb; 32(1):10. PubMed ID: 23442927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNA-mediated tumor specific delivery of TRAIL reduced glioma growth.
    Bo Y; Guo G; Yao W
    J Neurooncol; 2013 Mar; 112(1):27-37. PubMed ID: 23338605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA regulation of TRAIL expression exerts selective cytotoxicity to prostate carcinoma cells.
    Huo W; Jin N; Fan L; Wang W
    Mol Cell Biochem; 2014 Mar; 388(1-2):123-33. PubMed ID: 24292881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-661 Enhances TRAIL or STS Induced Osteosarcoma Cell Apoptosis by Modulating the Expression of Cytochrome c1.
    Fan L; Zhu C; Qiu R; Zan P; Zheng Z; Xu T; Li G
    Cell Physiol Biochem; 2017; 41(5):1935-1946. PubMed ID: 28391262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
    Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
    Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient melanoma cell killing and reduced melanoma growth in mice by a selective replicating adenovirus armed with tumor necrosis factor-related apoptosis-inducing ligand.
    Fecker LF; Rückert S; Kurbanov BM; Schmude M; Stockfleth E; Fechner H; Eberle J
    Hum Gene Ther; 2011 Apr; 22(4):405-17. PubMed ID: 20977303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
    Xu M; Xie Y; Sheng W; Miao J; Yang J
    Technol Cancer Res Treat; 2015 Aug; 14(4):369-78. PubMed ID: 25326586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
    Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective expression of tumor necrosis factor-related apoptosis-inducing ligand mediated by microRNA suppresses renal carcinoma growth.
    Zhang Z; Zhang H; Li H; Chen X; Liu M; Liu D; Zhao Y; Kong X
    Mol Cell Biochem; 2014 Jul; 392(1-2):125-34. PubMed ID: 24788726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophageal cancer-selective expression of TRAIL mediated by MREs of miR-143 and miR-122.
    Zhou K; Yan Y; Zhao S
    Tumour Biol; 2014 Jun; 35(6):5787-95. PubMed ID: 24659424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Patiño-García A; Zalacain M; Folio C; Zandueta C; Sierrasesúmaga L; San Julián M; Toledo G; De Las Rivas J; Lecanda F
    Clin Cancer Res; 2009 Aug; 15(16):5082-91. PubMed ID: 19671856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcoma.
    Wang Y; Li L; Shao N; Hu Z; Chen H; Xu L; Wang C; Cheng Y; Xiao J
    Acta Biomater; 2015 Apr; 17():115-24. PubMed ID: 25595474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-inducible human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy: a novel treatment for radioresistant uveal melanoma.
    Zhou Y; Song X; Jia R; Wang H; Dai L; Xu X; Gu P; Ge S; Fan X
    Pigment Cell Melanoma Res; 2010 Oct; 23(5):661-74. PubMed ID: 20546535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased miR-134 expression and its tumor-suppressive function in human osteosarcoma.
    Bao Y; Peng L; Ma J; Liu K; Li W
    Genet Mol Res; 2015 Dec; 14(4):16771-81. PubMed ID: 26681023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells.
    Liu J; Ma L; Li C; Zhang Z; Yang G; Zhang W
    Mol Oncol; 2013 Dec; 7(6):1043-55. PubMed ID: 24001901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical models.
    Guiho R; Biteau K; Grisendi G; Chatelais M; Brion R; Taurelle J; Renault S; Heymann D; Dominici M; Redini F
    Cytotherapy; 2018 Aug; 20(8):1037-1045. PubMed ID: 30093324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase.
    Cenni V; Maraldi NM; Ruggeri A; Secchiero P; Del Coco R; De Pol A; Cocco L; Marmiroli S
    Int J Oncol; 2004 Dec; 25(6):1599-608. PubMed ID: 15547696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.